← Back to catalogue

BioFire® COVID-19 Test 2

FDA UDI

Class II (US FDA UDI)

by BioFire Defense, LLC

Identity

Trade Name
BioFire® COVID-19 Test 2 FDA UDI
Generic Name
SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI
Device Name
BioFire® COVID-19 Test 2 - IVD reagent kit containing 30 tests FDA UDI
Model / Reference
DFA2-ASY-0016 FDA UDI
Description
BioFire® COVID-19 Test 2 - IVD reagent kit containing 30 tests FDA UDI

Identifiers

Catalog Number
DFA2-ASY-0016 FDA UDI
Primary DI / UDI-DI
00851458005235 FDA UDI
510(k) Number
K211079 FDA UDI
K221460 FDA UDI
FDA Product Code
QQX FDA UDI
GMDN Term
SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.3981 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)

BioFire® COVID-19 Test 2 by BioFire Defense, LLC — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT).

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI bf8b7ffb-22f3-4cfc-8132-b5a0ca18a387 36 fields · synced Jun 6, 2026